Neubase Therapeutics Inc Stock Forecast
Green day on Thursday for Neubase Therapeutics Inc
(Updated on Apr 18, 2024)
The Neubase Therapeutics Inc stock price gained 3.26% on the last trading day (Thursday, 18th Apr 2024), rising from $0.420 to $0.434. During the last trading day the stock fluctuated 7.32% from a day low at $0.410 to a day high of $0.440. The price has risen in 6 of the last 10 days and is up by 0.84% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 17 thousand more shares were traded than the day before. In total, 48 thousand shares were bought and sold for approximately $20.76 thousand.
The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.374 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -15.40% during the next 3 months and, with a 90% probability hold a price between $0.317 and $0.86 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
NBSE Signals & Forecast
A buy signal was issued from a pivot bottom point on Tuesday, April 09, 2024, and so far it has risen 9.77%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Neubase Therapeutics Inc has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Neubase Therapeutics Inc stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.696. On a fall, the stock will find some support from the short-term average at $0.418. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.
Support, Risk & Stop-loss for Neubase Therapeutics Inc stock
Neubase Therapeutics Inc finds support from accumulated volume at $0.426 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0300 between high and low, or 7.32%. For the last week, the stock has had daily average volatility of 7.63%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (NBSE) For The Upcoming Trading Day Of Friday 19th
For the upcoming trading day on Friday, 19th we expect Neubase Therapeutics Inc to open at $0.428, and during the day (based on 14 day Average True Range), to move between $0.374 and $0.493, which gives a possible trading interval of +/-$0.0595 (+/-13.72%) up or down from last closing price. If Neubase Therapeutics Inc takes out the full calculated possible swing range there will be an estimated 27.44% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $0.435 (0.25%) than the support at $0.426 (1.75%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Neubase Therapeutics Inc stock A Buy?
Neubase Therapeutics Inc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Current score: -3.295 Sell Candidate Unchanged
Predicted Opening Price for Neubase Therapeutics Inc of Friday, April 19, 2024
| Fair opening price April 19, 2024 | Current price |
|---|---|
| $0.428 ( 1.32%) | $0.434 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for NBSE
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 0.458 | 5.60 % | |
| R2 | 0.446 | 2.95 % | ||
| R1 | 0.439 | 1.32 % | ||
| Current price: | 0.434 | |||
| Support | S1 | 0.416 | -3.97 % | |
| S2 | 0.409 | -5.60 % | ||
| S3 | 0.398 | -8.24 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 0.479 | 10.42 % | |
| R2 | 0.450 | 3.76 % | ||
| R1 | 0.435 | 0.254 % | ||
| Current price | 0.434 | |||
| Support | S1 | 0.426 | -1.75% | |
| S2 | 0.402 | -7.29% | ||
| S3 | 0.400 | -7.68% |
FAQ
Click here for our free guide on how to buy Neubase Therapeutics Inc Stock.
